Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.51 USD | +0.87% | -0.70% | -1.79% |
Apr. 24 | Andersons Insider Sold Shares Worth $531,429, According to a Recent SEC Filing | MT |
Mar. 01 | BACKGROUND/Capital Markets Day at Bayer: To split up or not? | DP |
Financials (USD)
Sales 2024 * | 13.47B | Sales 2025 * | 13.73B | Capitalization | 1.91B |
---|---|---|---|---|---|
Net income 2024 * | 87M | Net income 2025 * | 110M | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
17.5
x | Employees | 2,259 |
Yield 2024 * |
1.34% | Yield 2025 * |
1.38% | Free-Float | 94.24% |
Latest transcript on The Andersons, Inc.
1 day | +0.87% | ||
1 week | -0.70% | ||
Current month | +2.86% | ||
1 month | -0.95% | ||
3 months | +8.07% | ||
6 months | +7.09% | ||
Current year | -1.79% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Bowe
CEO | Chief Executive Officer | 65 | 15-11-01 |
Brian Valentine
DFI | Director of Finance/CFO | 54 | 18-07-31 |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert King
BRD | Director/Board Member | 68 | 05-07-28 |
Director/Board Member | 60 | 07-11-30 | |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 45 M€ | +1.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 56.51 | +0.87% | 106,681 |
24-05-02 | 56.02 | +1.93% | 108,013 |
24-05-01 | 54.96 | +0.04% | 121,316 |
24-04-30 | 54.94 | -4.07% | 208,798 |
24-04-29 | 57.27 | +0.63% | 100,178 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.79% | 1.91B | |
+2.23% | 1.95B | |
+3.52% | 1.37B | |
-1.29% | 1.06B | |
-13.26% | 1.02B | |
-9.26% | 1.01B | |
-16.58% | 904M | |
+12.79% | 754M | |
-3.48% | 436M | |
-66.86% | 358M |
- Stock Market
- Equities
- ANDE Stock